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Numerous publications during the last quarter of a century have described
a large number of esters of basic amino-alcohols which have significant anti-
spasmodic activity (Blicke, 1944; Levy, 1948; Levy and Tchoubar, 1952). More
recently, an attempt has been made to describe the relationship between struc-
tural configurations favorable for stimulation and blockade at the acetylcholine
sensitive receptors of cholinergically innervated organs (Lands, 1951 ; Luduena
and Lands, 1954; Long et al., 1956) and these communications have provided
evidence which indicates that the muscarine-sensitive receptors are of a single
type with similar if not identical properties.
Our investigations now have been extended to the study of the antispasmodic
activity of a large number of new compounds. A considerable portion of these
have been supplied by Blicke’ and the synthetic methods involved are described
elsewhere (Blicke et ai., 1944, 1952, 1955). This communication presents various
basic screening data and discusses some of the relationhips between molecular
structure and cholinolytic activity which these data suggest.
METHODS. The screening of antispasmodic compounds has been carried out with isolated
segments of rabbit ileum suspended in Tyrode solution maintained at 38#{176}C.(Miller, Becker,
and Tainter, 1948). In some instances, a more recent modification (Luduena and Lands,
1954) was used. In this modified method, the experimental drug was added to the bath
solution two minutes after ACh and the resultant reduction in contracture occurring within
two minutes after addition of the spasmolytic drug expressed in per cent of the total con-
tracture. After two minutes of exposure to the antispasmodic drug, the bath solution was
removed, the intestinal segment washed twice with fresh Tyrode solution and again after
a five-minute period of immersion. The spasmolytic effect of four or five concentrations,
graded at 0.3 logarithmic intervals, was determined for intestinal segments from at least
eight rabbits. The concentration that would be expected to produce a 50 per cent reduction
was estimated from the (lose-response curves. We have considered an activity of loo that
of atropine sulfate as significant spasmolytic activity. Less potent compounds may have
an important papaverine-like component of action.
Effect on pilocarpine-induced salivary flow in adult albino rabbits has been determined
by the method described by Luduena and Lands (1954).
Acute toxicity was determined in albino mice by intravenous injection. The approximate
dose that would be expected to kill 50 per cent of the injected mice within 24 hours (LD,0)
has been determined in most instances by a short method in which three mice were injected
at three or more dose levels, the doses graded at 0.3 log intervals. In some instances, a more
exact value was obtained by injecting intravenously 10 mice at each of three or more dose
levels, the doses being graded at 0.1 log intervals. In these instances, mortality at 24 hours
has been computed and expressed as the LD50 ± SE., in mgm./kgm. (Hoppe et al, 1949).
‘University of Michigan.
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RESULTS. 1 . 2-Diethyiaminoethyl 3-hydroxy-2-phenylalkanoates. Previous in-
vestigation (Lands, 1951) has shown that relatively small changes in the structure
of the acetate portion of acetylcholine-like compounds will bring about a change
in the character of the response elicited in parasympathetically innervated organs,
from excitation to inhibition. This may be illustrated by 2-diethylaminoethyl
acetate, in which substitution of the terminal methane of the acid portion of
the ester by a hydroxyl and/or cyclic groups converts the ester to a compound
devoid of cholinomimetic properties (Lands et al., 1946 ; Lands, 1951). The
presence of two aryl, alkyl or aralkyl groups in addition to the hydroxyl leads
to an enhancement of cholinolytic action. The investigations of Halpern (1938)
and Dupre, Levy and Tchoubar (1946) have shown the effectiveness of aliphatic
groups larger than ethyl as one of the substituents on the acetate portion of
the ester.
We have extended our investigation of cholinolytic activity to include a large
number of 3-hydroxy-2-phenylalkanoates, synthesized by Blicke et al. (1952,
1955), and made available to this laboratory for pharmacologic evaluation.
Important spasmolytic activity was obtained with 2-diethylaminoethyl 9-
hydroxy-a-phenylbutyrate HC1 (No. 1, table 1). This action was greatest with
Nos. 15, 16 and 21 among the hydrochloride salts; Nos. 5a, 16a and 20a among
the methohalide salts. The alkyl substituent on the acetate (R, R’) may be as
large as cyclooctyl (No. 21) or as small as propyl (No. 5) without a change in
the order of magnitude of cholinolytic potency. In general, the methobromide
quaternaries are more potent than the corresponding hydrochlorides. Quaterniza-
tion causes a distinct increase in acute toxicity, as determined in mice by intra-
venous injection.
Structural variation of the quaternizing group leads to important differences
in cholinolytic potency. This is illustrated by the results obtained with the
quaternary salts of 2-diethylaminoethyl a-phenyl-a-(1-hydroxycyclohexyl)-
acetate HC1 (No. 16) as shown in table 2-A. Maximum activity was obtained
with the metho- and ethobromides, the latter having a potency of 118 per cent
that of atropine sulfate. The benzyl- and phenacyibromide quaternaries have
cholinolytic potencies distinctly less than that of the ethobromide.
When cholinolytic activity of the hydrochloride salt is of the same order as
that of atropine sulfate, quaternization may cause little or no further increase in
potency. Thus, with 2-diethylaminoethyl a-cyclopentyl a-hydroxy-a-(2-thienyl)-
acetate HC1 (No. 64) in which cholinolytic potency exceeds that of atropine,
quaternization to form the metho- or ethobromide results in no further increase
(table 2-B).
Acute intravenous toxicity in mice was greatest for the allylbromide (No.
16c) and least for the benzylbromide (No. 16d) quaternary salts of 2-diethyl-
aminoethyl-ce-phenyl-a-(1-hydroxy-cyclohexyl) acetate. The values obtained
do not correlate with those for cholinolytic action and this suggests that lethality
resulted largely from effects in some physiologic system other than that involved
in this action.
2. 2-Diethylaminoethyl 3-hydroxy-2-cyclohexylalkanoates. The previous section
TABLE 1
A comparison of cholinolytic activity on the rabbit isolated intestinal segment and acute toxicity
















1 H CII, HC1 15 56.0 ± 6.0
la CH3Br 33 21.0 ± 2.0
2 CH, CII, HC1 10
3 CII, C,I1 HC1 9 53
4 H C,H5 HC1 35 70
5 H C,H7 HC1 25 60
5a CH,Br 100 18
6 H CH(CH,)2 HC1 12 60
6a CH,Br 11 15
7 H CH(C,H,), HC1 3
8 H () HC1 4 44
9 H ,/\ HC1 10 28
Oa CH,Br 44 8
10 H ,/‘ HC1 15 36
lOa / CH,Br 28 9
ii H HC1 23 62
Ha \ CH,Br 62 12
12 H C6H,,(n) HC1 5 31
12a CH,Br 53 6
13 H HC1 28 6
13a CII,Br 60
14 C,H5 C2H5 HC1 3
15 CII,-CH, HC1 112
CH,-CII2
16 CH2-CH, HC1 43 50.0 ± 4.0


















17 CH,-CH,-CH, HC1 27 47.0 ± 3.5
17a CH,-CH,---CH, CH,Br 41 10.9 ± 1.1
18 CH,-CII, HO! 11





19 011,-OH, HC1 5 38





20 CH,-CH, HCI 29 38




21 CH2-CH2-CH, HO! 41 44




* Values tabulated are based upon the effective concentration of drug (Luduena and
Lands, 1954) in comparison with that of atropine sulfate. Contracture was induced by ACh,
added to give a final concentration of 1:1,000,000.
t Acute intravenous toxicity in mice. The tabulated value is an approximate LDbo,
unless given with the standard error.
described a series of esters in which a phenyl group is one of the substituents in
the acid portion of the ester. Levy et al. (1948) and Buchel et al. (1948) have
reported that the spasmolytic activity of cyclohexyl- and cyclohexenylalkanoate
esters is comparable to that of the corresponding phenyl analogs. We have been
able to examine this matter further by the use of a series of cycloalkyl substituted
esters (Blicke et al., 1952,1955). Results obtained are shown in table 3. Significant
spasmolytic action (more than 1 per cent that of atropine sulfate) was observed
with most of these compounds. It is interesting to note that No. 30 and the
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TABLE 2
The influence of the quaternizinlj group on the cholinolytic activity and toxicity of esters of
2-diet hylaminoet hanol
Cholinolytic






































64*1 HO! 200 80.0 ± 6.0
64a* CII,Br 210 16.0 ± 1.4
64b O,H,Br 200 18.0 ± 0.8
* Luduena andiLands, 1954.
t Blicke, F. F., U. S. Patent 2,541,634 (Feb. 13, 1951).
 ACh contracture, rabbit isolated intestinal segment.
corresponding phenyl analog (No. 15) are the most potent hydrochloride salts.
Conversion to the methobromide quaternary salt resulted in a distinct increase
in this activity. The quaternary salts also were distinctly more toxic than the
corresponding hydrochlorides, but there does not appear to be any direct relation-
ship between spasmolytic potency and acute toxicity.
3. -Diethylaminoethyl cyclopentylal kylacet ales. The preceding section has
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TABLE 3
A comparison of the cholinolytic activity on the rabbit isolated intestinal segment and acute












22 H H HO! 6 88.0±7.0
22a CH,Br 19 23.0 ± 1.9
23 OH, OH, 1101 5 75
23a CH,Br 14 22
24 H 0,11, 1101 7.1 63
24a CH,Br 23.2 22
25 11 0,117 HO! 6 42
25a OH,Br 44 19
26 OH, 0,11, HO! 21 60
26a CH,Br 48 18
27 H OH(CII,), HO! 3 38
27a OH,Br 14 16
28 O,H, C,H, HO! 7 50
28a OH,Br 32 16
29 C,H7 O,H, HO! 0.2 31
OH,Br 0.8 5
30 OH,-CH, 1101 33 37.0 ± 2.0
30a OHs-OH: OH,Br 104 16
31 OH,-OH, 1101 9 44
OH,
/
31a OH,-OH, OH,Br 62 16
32 OH,-OH,--CH, HO! 8 44.0 ± 2.6
32a OH,-CH,-CH, OH,Br 50 10.2 ± 0.5
33 OH,-CH, 1101 3 44
OH-OH,
/






















34a CH,-CH,-OH, CH,Br 7.7 8
35 H C,H,, HOl 2 42
35a CH,Br 13.5 11
36 H C,H,, HOI 1.3 30
36a CH,Br 18.5 13
37 H C,H,, HO! 0.5 8
37a OH,Br 18.5 4
38a OH, KII> CH,Br 3.2 4
* See footnote, table 1.
described high spasmolytic potency with 2-diethylaminoethyl esters of aliphatic
acids indicating that the aromatic group is not essential. The cyclohexyl ring
may also be replaced by a cyclopentyl ring and still provide esters of aliphatic
acids with significant spasmolytic activity. Moffett et al. (1950) have synthesized
and made available to this laboratory the series of cyclopentyl substituted com-
pounds shown in table 4. Although they do not have a hydroxyl and are not
quaternized, spasmolytic potencies of 2 to 38 per cent that of atropine sulfate
were obtained. The most active compound, No. 41, has a potency comparable to
that of 2-diethylaminoethylphenylcyclohexylacetate HCI (No. 48, Trasen-
tine 6-H).
4. 2-Dialkylaminoethylphenyl- or thienylalkylacetates and -glycolates. From
the results presented in the preceding sections, it is clearly apparent that potent
spasmolytic compounds may be obtained from 2-diethylaminoethyl esters of a
large variety of aliphatic and arylaliphatic acids. Levy et al. (1948) have shown
the 2-diethylaminoethyl esters of cyclohexyl- and cyclohexenylpropionic,
-butyric and -hexanoic acids are potent spasmolytic agents and more potent
than the corresponding phenyl analogs. We have extended our investigation of
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TABLE 4
A comparison of the cholinolytic activity on the rabbit isolated intestinal segment and acute














39 OH(OH,), 6 50
40 OH, 6 34




45 OH(CH,)O11,CH,OH, 2 31
46 011,011 (OH,)OH,CH, 4
47 011,011 (0,11,), 12 25
48 2-diethylaminoethy! phenylcyclohexylacetate 26
49 2-diethylaminoethyl dicyc!ohexylacetate 16
S Moffett, R. B., and Hart, C. A., U. S. Patent 2,538,792 (Jan. 23, 1951.)
t See footnote, table 1.
spasmolytic agents to include esters of thienylaliphatic (Blicke and Tsao, 1944)
as well as cycloalkyl- and phenyl-substituted esters. Results obtained are shown
in table 5.
The presence of a hydroxyl group on either the first or second carbon from the
carboxyl greatly increases cholinolytic action. A comparison of the spasmolytic
potency of No. 51 (table 5) with No. 6 (table 1) shows that while the former is
more potent than the latter, their potencies are of the same order of magnitude.
The phenyl group may be replaced by a thienyl group without important changes
in potency as is shown by a comparison of No. 54 (phenyl) and No. 56 (thienyl).
These compounds have spasmolytic potencies of 36 and 47 per cent that of
atropine sulfate. The spasmolytic values obtained from No. 51 (phenyl) and No.
53 (thienyl) are equally close. This generalization appears to be applicable also
to the analogs in which a cycloalkyl has been substituted for an alkyl group.
No. 60 (thienyl) has a spasmolytic potency of 80 per cent that of atropine sulfate
which is comparable to that of the corresponding phenyl analog, No. 61 (2-di-
ethylaminoethyl phenylcyclohexylhydroxyacetate) with a potency of 60 per cent.
Although the major portion of the data presented here was obtained in screen-
ing tests on the isolated rabbit ileum, a few of the more potent compounds were
examined for cholinolytic action in the intact animal. Blockade of pilocarpine-

















































































* See footnote, table 1.
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1 Values taken from Plummer, Barrett, Rutledge and Yonkman, 1953.
TABLE 5
A comparison of the cholinolytic activity on the rabbit isolated intestinal segment and acute
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TABLE 6















































* Luduena and Lands, 1954.
Luduena and Lands (1954) with the results shown in table 6. The quaternary
methobromides are distinctly more effective than the corresponding tertiary
amines. The potency of 2-diethylaminoethyl 3-hydroxy-2-phenylbutanoate
hydrochloride (No. 1) is of the same order of magnitude as that of homatropine,
the corresponding methobromide being comparable in potency to homatropine
methobromide.
The cholinolytic actions of 2-diethylaminoethyl cyclopentythydroxy-(2-
thienyl)acetate (No. 64) and the corresponding methobromide salt have been
described in a previous publication (Luduena and Lands, 1954). The ethobromide
(No. 64b), shown in table 2, has been examined for cholinolytic action in anes-
thetized dogs with results as follows, expressed as ED,0 values in microgm./kgm.
for intravenous administration: spasmolysis of the small intestine, 1.88; blockade
of carbamyicholine induced salivation, 1.62; blockade of carbamylcholine induced
vasodepression, 1.33. The corresponding approximate values for No. 60a are
4.0, 2.0 and 2.0 microgm./kgm. These data support the view that the intestinal
screening data provide an indication of the general order of cholinolytic activity
in the various compounds described in this communication.
5. Miscellaneous esters of 2-diethykiminoethanol. This exploration of the esters
of 2-diethylaminoethanol in an effort to determine the optimum configuration of
the acid portion for effective blockade of the acetylcholine-sensitive receptors of
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parasympathetically innervated organs led to the evaluation of several com-
pounds wherein the structure was too varied for tabulation in the first six tables
of the preceding sections. The compound obtained by partial saturation of the
ring (2-diethylaminoethyl &-cyclopentenyl-isoamylacetate HCI) is not sig-
nificantly different in spasmolytic potency from the close phenyl and cyclopentyl
analogs shown in tables 4 and 5. It was found that 2-diethylaminoethyl 2-cyclo-
hexenyl-i’-cyclopenteny1acetate has spasmolytic potency comparable with
that of 2-diethylaminoethylphenyl-cyclohexylacetate HC1 (Trasentine 6-H,
No. 48).
Some modification of the structure of the acid portion of the ester, as repre-
sented by No. 8 and 2-diethylaminoethyl a-(2-hydroxyhydrenyl)-phenylacetate
hydrochloride, wherein the position of the hydroxyl is varied relative to the
carboxy group is permissible without a large loss of activity. However, a similar
lengthening of this distance by interposing -CII,- between the hydroxyl
and the carbon atom bearing the cyclic substituents as illustrated by 2-diethyl-
aminoethyl a-phenyl-a-cyclohexyl-3-hydroxypropionate hydrochloride and 2-
diethylaminoethyl a-benzyl-a-phenyl-3-hydroxypropionate hydrochloride does
not favor spasmolytic action.
a. Dialkylaminoalkylmercapto esters of organic acids. Benoit et al. (1951) have
described the spasmolytic activity of diphenyl-1 , 1-diethylamino-w-alkanes in
which the distance between the terminal methane and the amino group varied
from 1-6 carbons. They reported maximal activity at 4 and 6 carbon distances,
these compounds being 6-15 times more potent than 2-diethylaminoethyl di-
phenylacetate (Trasentine). We have investigated the spasmolytic activity of a
series of long chain mercapto derivatives shown in table 7-A. Spasmolytic ac-
tivity of these esters is not great, the most active having a potency of less than
1 per cent that of atropine. These compounds are slightly longer than the longest
member of the series described by Benoit et al. (1951) and may be too long for
proper attachment to the parasympathetic receptor site. Also, the large sulfur
atom may not favor attachment. We have included for comparison two com-
pounds of similar length, 2-diethylaminoethoxyethyl diphenylacetate hydro-
chloride and 4-diethylamino-2-butenyl diphenylacetate hydrochloride, in which
the sulfur moiety is not present. They appear to be somewhat more spasmo!ytic
(activity ratios of 1 per cent) than the thiol analogs but with activity that is at
the lower limit of significance.
b. Alkylaminoalkanoic acid esters. Schueler ci at. (1951) have shown that
methyl-2-trimethylammonium propionate bromide (reversed ester of ACh) has
muscarinic activity of a high order. The corresponding triethylammonium
analog is considerably less stimulating, requiring doses of 1-2 mgm./kgm. intra-
venously in dogs to elicit vasodepressor responses. We have included in this in-
vestigation the spasmolytic data obtained with a series of diphenyl- and phenyl-
cyclohexyl substituted benzohydryl alkanoates in which the terminal carbon
of these “reversed esters” have been modified as in the antispasmodic groups
described in preceding sections. Results obtained are shown in table 7-B. None
of these compounds were found to have significant spasmolytic action.




A comparison of the cholinolytic activity on the rabbit isolated intestinal segment of a mis.
cellaneous group of synthetic esters of basic amine8





3-(2-Dimethylaminoethylmercapto)-2-propyl diphenylacetate citrate, 2-(2-diethyla-
minoethylthio)ethyl fluorene-9-carboxylate citrate, 3-(2-dimethylaminoethylthio(-propyl-
fluorene-9-carboxy!ate citrate, 3-(2-diethy!aminoethylthio)-2-propyl phenylcyclohexyl-
acetate citrate, diethylaminoethy!thioethy! phenylcyclohexylacetate citrate have oholino-
lytic activities of 0.1-0.4. The cholinolytic activities of 2-diethy!aminoethoxyethyl di-
pheny!cetate hydrochloride and 4-diethylamino-2-butenyl diphenylacetate hydrochloride
are 1.0.
B. HO! 0.3
Benzohydryl diethylaminoacetate hydrochloride, benzohydryl 3-piperidinopropionate
hydrochloride, benzohydryl 3-morpholinopropionate hydrochloride have cho!inolytic ac-
tivities of 0.1 or less.Similarly, cyclohexylphenylmethyl 3-(N-2-methylpiperidy!)-propano-
ate hydrochloride and the corresponding diethy!aminopropionate hydrochloride are weak
antispasmodics with cholinolytic acitivities of less than 2.
C. 110! <2
Isopropy! 2,2-dipheny!-4-dimethylaminobutanoate hydrochloride, ethyl 2,2-diphenyl-
4-dimethylaminobutanoate methiodide, ethyl 2,2-dipheny!-4-N-morpholinylbutanoate
methiodide, ethyl 4-dimethylamino-2,2-diphenylpentanoate hydrochloride all have















Ethyl 9-(2-N-piperidylethyl)-fluorene-9-carboxylate hydrochloride has a cholinolytic
activity of 2.5.
E. HC1
Diethylaminoethy! diphenylethylacetate hydrochloride has a cholinolytic activity of
3. 3-N-Piperidylpropyl 2,2-diphenylbutanoate hydrochloride, 1-methyl-2-dimethylamino-
ethyl 2,2-diphenylbutanoate hydrochloride, dimethylaminoethyl 2,2-diphenylbutanoate
hydrochloride, dimethylaminoethyl 2,2-diphenylbutanoate methiodide, N-piperidyliso-
propyl 2,2-diphenylbutanoate methiodide and 2-N-piperidylethyl 2,2-diphenylbutanoate
hydrochloride all have cholinolytic activity of less than 2.
* See footnote, table 1.
cyano group to the aryl substituted carbon does not diminish significantly
spasmolytic potency (Lands et al., 1949). Substitution of larger groups, as shown
in table 7-C, does not favor spasmolytic activity. These compounds are weak
and appear to be somewhat less effective than the corresponding aminoalkane
and -alkanols (Lands and Luduena, 1956). The somewhat more compact
structure in which the benzene rings are incorporated into the fluorene structure
(table 7-D) have spasmolytic potencies comparable to that of the corresponding
diphenylacetates.
A series of dialkylaminoalkyl 2, 2-diphenylbutanoates (table 7-E) were ex-
amined for spasmolytic potency with results similar to those previously de-
scribed. Activity was not great in any instance and was greatest with 2-diethyl-
aminoethyl diphenylethylacetate HO! which has a spasmolytic potency of 3 per
cent that of atropine sulfate. This compound is not more spasmolytic than the
corresponding diphenylacetate ester.
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DISCUSSION. In previous communications from this laboratory, we have sug-
gested that the ACh sensitive receptor surface of parasynipathetically innervated
organs have quite similar or identical properties; that the reactive surface lies
within an area about 10 A in length (measured from the nitrogen center) by
5 A in width ; that reatest activity is obtained when there is a hydroxyl group
at a distance of 4-7 A from the cationic head ; that there should be present on the
carbon near the hydroxyl an umbrella-like mass which may form a protecting
shield and/or an additional attracting force for atachment to the receptor surface
(Lands, 1951 ; Lands and Cavallito, 1954; Luduena and Lands, 1954; Lands and
Luduena, 1956). The large number of structurally diverse esters described in
this communication provides an additional opportunity for evaluating this
concept.
The influence of chain length (distance between N and terminal methane of
the hydrocarbon chain) is most simply determined by the series of 1 , 1-diphenyl-
diethylamino-w-alkanes described by Benoit et at. (1951). Two optimal chain
lengths were reported at 7.5 and 10.5 A from the N. There was no hydroxyl group
present, so one may assume that the additional attracting forces were supplied
by the phenyl rings substituted on the terminal carbon. Inasmuch as the un-
substituted five carbon analog is cholinomimetic rather than cholinolytic, the
phenyl rings determined the nature of the action of the molecule. Introduction
of a hydroxyl into the appendage group at a distance of 4.5 A (or on the third
carbon from the N) in the four carbon analog (McManus ci at., 1954; Schultz
ci at., 1952) results in a compound with cholinolytic potency not appreciably
greater than that of the corresponding alkane. However, when one phenyl group
is replaced by a propyl or isopropyl group, cholinolytic potency is one to five per
cent that of atropine sulfate. Reduction of the appendage group to three carbons
and substitution of the terminal carbon with a hydroxyl and two phenyl rings
results in a compound with cholinolytic potency of 50-100 per cent that of
atropine sulfate (White ci at., 1951). Inasmuch as the three carbon distance is
near the critical limit (Lands and Luduena, 1956), relatively small structural
changes may prevent close approach of the hydroxyl to the reactive site. The ob-
servation that a carbamyl group may replace the hydroxyl without a resultant
loss of significant activity is of interest (Schaumann and Lindner, 1951; Cheney
ci at., 1952; de Jong ci at., 1955; van Proosdij-Hartzema ci at., 1955). This group
also appears in the potent cholinomimetic drug, carbaminoylcholine (Doryl,
Lentin, Carcholin).
The Blicke modifications shown in tables 1 and 2 indicate the large variety of
structures which may be substituted on the hydroxyl bearing carbon atom with-
out loss of significant cholinolytic activity. These results are similar to those
obtained with comparable glycolates (Lands et at., 1946, 1951) and indicate
that the nature of these modifications are less critical than chain length or the
presence of a hydroxyl group.
Schueler and Keasling (1951) described potent cholinomimetic compounds
in their series of “reversed ester” analogs of ACh. One might reasonably expect
that appropriate substitution of the terminal carbon would provide potent
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cholinolytic compounds. This was not realized with the compounds shown in
table 7-B. The reversed ester analog of Trasentine is clearly less potent than the
latter. The -C : 0- at a distance of 3 A from the N is not opposite the positive
center involved in attachment (Long et al., 1956) and may provide steric
hindrance to receptor attachment.
We have previously referred to the carbamyl substituted compounds. A modifi-
cation of several potent cholinolytic esters is shown in table 7 (D and E) wherein
the terminal hydroxyl or carbamyl group has been replaced by an ethyl group;
the resultant compounds are either low in potency or are below the level of signifi-
cant action. However, the size of the ethyl substitutent is comparable to that of
the carbamyl group suggesting some specific importance for the latter similar to
that represented by a hydroxyl.
Quaterization of effective cholinolytic compounds to give the methyl- or
ethyihalide salt produces the expected increase in potency and is in agreement
with the findings of Fromherz (1933), Meier and Hoffmann (1941), Ing ci at.
( 1945) and many others. Recently, similar results have been described for a
series of optically active dialkylaminoalkanols, the cholinolytic activity being
due almost entirely to the levo component (Duffin and Green, 1955). The effect
of quaterization is amply illustrated by data given in tables 1-3. A four- or five-
fold increase in spasmolytic potency is not uncommon. These quaternary salts
also have curare-like actions (Fromherz, 1933) and are markedly more toxic than
the corresponding hydrochloride salts.
This communication provides data on a large number of new synthetic com-
pounds. It is the authors’ hope that the additional information will prove helpful
in the further elucidation of the relationship between chemical structure and the
nature of the receptor surface involved in the mediation of cholinergic nerve
impulses.
SUMMARY
Various phenyl, cycloalkyl and alkyl substituted $-hydroxybutyric acid esters
of 2-diethylaminoethanol have cholinolytic action comparable to that of the
corresponding hydroxyacetate esters.
The most effective compounds, within a variety of structurally diverse esters,
have a hydroxyl group at a distance of 4-7 A from the amine group. The re-
placement of the hydroxyl by a hydrogen atom greatly reduces cholinolytic
potency in most instances.
The various effective substitutions of the carbon atoms near the hydroxyl pro-
vide an umbrella-like mass which may form a protecting shield over the receptor
surface thereby preventing close approach of stimulating molecules such as
acetylcholine. The data suggest that other effects also may be important and
that these groups may in some specific way increase affinity for the receptor
site.
Quaternization of the amine to form the methyl- or ethylhalide salts increases
cholinolytic potency and toxicity. This is similar to the increase in cholinomimetic
potency and toxicity which is associated with methylhalide quaternization of
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various tertiary amines and may result, in part, from an increased reactivity of
the cationic group.
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